TRI to attend North East England Life Science Showcase – Boston, Nov 30

North East England is hosting a morning of networking, presentations and discussion alongside pharmaceutical and biotech businesses based in Boston.

Thu 30 November 2017,
08:30 – 15:00 EST

Boston Marriott Cambridge,
50 Broadway,
Cambridge, MA 02142

Program includes:
8:30am Networking and refreshments
9:00am Welcome and introduction
9:15am Company showcase and industrial insights

In vitro pre-clinical testing for predicting adverse immune reactions
Showcase by Prof. Anne Dickinson, Director, Alcyomics
Alcyomics is a unique pre-clinical service provider using Skimune®, non-artificial human skin explants for
safety and efficacy assessment of novel compounds and drugs.
Industry insights by Jessica Whritenour, Sr. Principal Scientist, Immunotoxicology CoE, Pfizer

Human Tissue- and 3D Cell-based Models for Drug Discovery
Showcase by Robert R. Annand Ph.D., Senior TechnicalProduct Manager, ReproCELL
REPROCELL’s pre-clinical contract research organization provides unique custom pharmacology assay services using freshly-sourced human tissues and 3D tissue models.
Industry insights from Steven Burke, Senior Vice President and Chief Executive Officer, Proteon Therapeutics

10.30am Coffee and networking
11:00am Continuation of showcasing and industry insights

Clinical Development Simplified
Showcase by Emma Banks, CEO, Datatrial
Datatrial are a technology focused business enabling end to end access to clinical data and documents via a single compliant platform – Nucleus.
Industry insights from Duncan Hall, CEO, TRI and Doris Sanchez, Sr. Director, Scientific Development, MedSource

Life sciences opportunities in the North East of England
Showcase by Matt Bratton, Senior Inward Investment Executive, Invest Newcastle
Supporting international businesses to locate in the North East of England, they will give an overview of the regionalstrengths and opportunities.

12:15pm Finger buffet lunch and networking

Please RSVP by Friday November 17th 2017 here or contact for further information.